NCT04951102

Brief Summary

This study will increase knowledge about the feasibility and effect on patient satisfaction and clinical outcomes of using an electronic Shared Decision Making (SDM) application (app) for patients with asthma in the allergy/immunology clinic visit setting. SDM is defined as an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients are supported to consider options and make informed choices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable asthma

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2022

Completed
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

1.1 years

First QC Date

June 4, 2021

Last Update Submit

November 16, 2022

Conditions

Keywords

AsthmaShared Decision MakingSDM

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction

    Patient satisfaction as determined by Patient Satisfaction Questionnaire responses. Questions will consist of the SDM-Q-9 (psychometrically validated measures for shared decision-making from the perspectives of patients), questions regarding satisfaction with content covered during the visit, and questions regarding satisfaction with the overall communication between the patient and physician.

    Within 1 week of completing asthma shared decision making app worksheet and their asthma clinic visit

Secondary Outcomes (2)

  • Physician satisfaction

    Within 1 week of patient visit

  • Change in level of asthma control will be determined

    Up to 6 months

Study Arms (4)

Group A Patients who receive SDM intervention

EXPERIMENTAL

Group A patients will complete a pre-visit electronic Asthma SDM App. They may also receive educational information regarding asthma, medication management, smoking cessation, COVID-19 and COVID-19 vaccines.

Behavioral: Electronic Asthma Shared Decision-Making App

Group B Patients who receive standard care

ACTIVE COMPARATOR

Group B patients will receive standard care.

Behavioral: Standard Care

Group A Physicians who receive SDM training and electronic Asthma SDM App data

EXPERIMENTAL

Group A physicians will view an SDM Physician Training Video and receive the patients' reported data from the pre-visit asthma SDM App prior to the patients' visits.

Behavioral: Shared Decision Making Physician Training VideoBehavioral: Electronic Asthma Shared Decision-Making App- Patient Data

Group B Physicians who provide standard care

ACTIVE COMPARATOR

Group B physicians will provide standard care.

Behavioral: Standard Care

Interventions

The electronic Asthma SDM App will ask questions related to medicine-related, non-medicine-related, and COVID-19-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment. They may also use the Asthma SDM app to find information about asthma, medication management, COVID-19 and COVID-19 vaccines.

Group A Patients who receive SDM intervention

Training video to educate physicians on Shared Decision-Making and the use of Shared Decision-Making tools.

Group A Physicians who receive SDM training and electronic Asthma SDM App data

Data from the pre-visit electronic Asthma SDM app completed by the patients. Data includes medicine-related, non-medicine-related, and COVID-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment.

Group A Physicians who receive SDM training and electronic Asthma SDM App data
Standard CareBEHAVIORAL

Standard Care for asthma.

Group B Patients who receive standard careGroup B Physicians who provide standard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • Diagnosis of persistent asthma
  • Have an in-person visit or telehealth encounter at the allergy/clinical immunology clinics participating in this study

You may not qualify if:

  • Diagnosis of intermittent asthma
  • Any other lung disease
  • Smoking greater than 20 pack years or current smoking
  • Mental impairment such that participation would not be possible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michigan Medicine, University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (1)

  • Lee DL, Hammond JW, Finkel K, Gardner DD, Nelson B, Baptist AP. An Electronic Shared Decision-Making App to Improve Asthma Outcomes: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3116-3122.e5. doi: 10.1016/j.jaip.2023.06.016. Epub 2023 Jun 16.

MeSH Terms

Conditions

Asthma

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Alan Baptist, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The subjects will be clustered in 2 groups of patients and physicians based on participating health care provider and clinic location. Group A will be the intervention group and Group B will be the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Internal Medicine

Study Record Dates

First Submitted

June 4, 2021

First Posted

July 6, 2021

Study Start

March 3, 2021

Primary Completion

March 28, 2022

Study Completion

September 14, 2022

Last Updated

November 17, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations